Stimovar Injection
Stimovar Injection
Authorised
- Gonadotropin, equine, serum
Product identification
Medicine name:
Stimovar Injection
Active substance:
- Gonadotropin, equine, serum
Target species:
-
Cattle
-
Goat
-
Sheep
-
Pig
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Gonadotropin, equine, serum7500.00international unit(s)1.00Vial
Pharmaceutical form:
-
Powder and solvent for solution for infusion
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal10day
-
Milk24hour
-
-
Goat
-
Meat and offal10day
-
Milk24hour
-
-
Sheep
-
Meat and offal10day
-
Milk24hour
-
-
Pig
-
Meat and offal10day
-
-
-
Subcutaneous use
-
Cattle
-
Meat and offal10day
-
Milk24hour
-
-
Goat
-
Meat and offal10day
-
Milk24hour
-
-
Sheep
-
Meat and offal10day
-
Milk24hour
-
-
Pig
-
Meat and offal10day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QG03GA03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Available in:
-
Ireland
Package description:
- 1000 IU: The PMSG Stimovar is contained in a clear 10 ml glass vial. Type II sealed with a butyl rubber stopper.The sterile diluent is contained in a clear 20 ml glass vial. Type II sealed with a butyl rubber stopper.Both Stimovar and sterile diluent are presented in a cardboard box, with instructions for use printed on the outside.Each pack contains an information leaflet on the use of the product.
- 7500 IU: The PMSG Stimovar is contained in a clear 10 ml glass vial. Type II sealed with a butyl rubber stopper.The sterile diluent is contained in a clear 20 ml glass vial. Type II sealed with a butyl rubber stopper.Both Stimovar and sterile diluent are presented in a cardboard box, with instructions for use printed on the outside.Each pack contains an information leaflet on the use of the product.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratorios Ovejero S.A.U.
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Ovejero S.A.U.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10396/002/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?: